Nanodroplets promise to reduce the equipment, cost and time constraints of high-throughput screening, if researchers can overcome long-standing hurdles.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Rights and permissions
About this article
Cite this article
Mullard, A. Microfluidics platform lowers barrier to drug combination screening. Nat Rev Drug Discov 17, 691–692 (2018). https://doi.org/10.1038/nrd.2018.161
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrd.2018.161
This article is cited by
-
Prediction of drug combination effects with a minimal set of experiments
Nature Machine Intelligence (2019)